Company / Operating Margin
Niagen Bioscience, Inc. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
12.6%
FY2025
5-year range
-40.1% / 12.6%
FY2021-FY2025
Trend
+287.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed +288% YoY in FY2025, a notable deviation from the 9-year average annual change of -4%.
Based on SEC 10-K filings.
12.6% in FY2025 with a 5-year CAGR of +80.2%.
Improved from -25.9% to 12.6% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +52.7pp
- 5-Year Change
- +80.2pp
- 10-Year Change
- -
Key checks
Key Insights
- Niagen Bioscience, Inc.'s operating margin has grown for 3 consecutive years.
- In FY2025, operating margin increased 287.8% year-over-year.
- Lowest operating margin in the period was in FY2018.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 12.6% | +287.8% |
| FY2024 | -6.7% | +74.1% |
| FY2023 | -25.9% | +35.6% |
| FY2022 | -40.1% | -19.8% |
| FY2021 | -33.5% | +50.5% |
| FY2020 | -67.6% | +0.0% |
| FY2019 | -67.6% | +12.5% |
| FY2018 | -77.3% | +0.0% |
| FY2017 | -77.3% | -476.1% |
| FY2016 | -13.4% | -16.1% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026